Suppr超能文献

[既往有静脉血栓栓塞症患者短暂风险期复发的预防]

[Prophylaxis of recurrence during transient risk in patients with previous venous thromboembolism].

作者信息

Schmidt Benjamin, Schellong Sebastian

机构信息

Bereich Angiologie, Medizinische Klinik III, Universitätsklinikum Carl Gustav Carus, Technische Universität, Dresden, benjamin.schmidt@ mailbox.tu-dresden.de

出版信息

Med Klin (Munich). 2003 Aug 15;98(8):447-52. doi: 10.1007/s00063-003-1284-7.

Abstract

BACKGROUND

Current data allows first recommendations for the management of patients with previous venous thromboembolism (VTE) whose risk of recurrence is transiently increased.

METHODS

The literature about the risk of VTE recurrence in common clinical situations is analyzed, and recommendations for the diagnostic and therapeutic management and patient counseling are given.

CONCLUSIONS

Perioperative replacement of oral anticoagulants by low molecular weight heparins (LMWH) is effective and safe in patients treated for VTE. After a triggered first episode of VTE, the same prophylaxis in situations of transient risk is recommended as for patients without previous VTE. Patients with previous VTE who are pregnant or scheduled for hormonal therapy require a detailed exploration, as management is influenced by several factors. In the postpartal period, patients with previous VTE should receive prophylactic anticoagulation. In malignant disease, anticoagulation should be continued over the time of active malignancy; LMWH appear to have a more favorable profile than oral anticoagulants.

摘要

背景

目前的数据允许对既往静脉血栓栓塞症(VTE)患者的管理提出初步建议,这些患者的复发风险会暂时增加。

方法

分析了关于常见临床情况下VTE复发风险的文献,并给出了诊断、治疗管理及患者咨询的建议。

结论

对于接受VTE治疗的患者,围手术期用低分子肝素(LMWH)替代口服抗凝药是有效且安全的。在首次触发VTE发作后,对于短暂风险情况,建议采取与无既往VTE患者相同的预防措施。既往有VTE的孕妇或计划接受激素治疗的患者需要详细评估,因为管理受多种因素影响。在产后阶段,既往有VTE的患者应接受预防性抗凝治疗。在恶性疾病中,抗凝治疗应在恶性肿瘤活跃期持续进行;低分子肝素似乎比口服抗凝药具有更有利的特征。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验